Do any peptides actually cause weight loss?

The medicines with large, replicated human weight-loss trials are the GLP-1 and GIP drugs — semaglutide and tirzepatide — which are peptide-based but are FDA-approved prescription medicines, not grey-market research peptides. Most of the 'peptides' marketed online for fat loss (BPC-157, MOTS-c, 5-Amino-1MQ, GH secretagogues, etc.) have little or no human evidence for weight loss.

Are research peptides FDA-approved?

Almost none of the grey-market research peptides are FDA-approved. A few molecules are approved for specific, unrelated indications (tesamorelin for HIV lipodystrophy; bremelanotide as Vyleesi for sexual desire disorder), and some are approved abroad but not in the US (thymosin alpha-1). 'For research use only' on a label means it is not an approved human medicine.

Is it safe to inject peptides bought online?

Unregulated injectable peptides carry real risks: the product's identity, dose, sterility, and purity are not guaranteed, and several marketed peptides have documented safety concerns. This guide is educational and not medical advice; discuss any peptide with a licensed clinician.

Are peptides the same as Ozempic?

Ozempic and Wegovy (semaglutide) are themselves peptide medicines — GLP-1 receptor agonists — so in a literal sense they are peptides. But they are FDA-approved prescription drugs backed by large randomized trials, which is a completely different category from the grey-market 'research peptides' (BPC-157, MOTS-c, GH secretagogues, and similar) sold online for fat loss. Being 'a peptide' tells you nothing about whether a compound is approved, effective, or safe; the label that matters is whether there is human trial evidence and regulatory approval for the use in question.

Who should avoid research peptides?

Because grey-market research peptides are unapproved, unregulated, and largely untested in humans for their marketed uses, the honest answer is that no one should use them without a licensed clinician's involvement. The concern is heightened for anyone who is pregnant or breastfeeding, has a personal or family history of cancer (given the theoretical role of GH/IGF-1-raising peptides in tissue growth), or is a competitive athlete subject to WADA anti-doping rules, since many of these peptides are banned. If weight loss is the goal, the FDA-approved GLP-1 and GIP/GLP-1 medications have far stronger evidence and should be discussed with a prescriber instead.

Peptides A-Z: Evidence-First Guide to Every Peptide

At a glance

1 approvedOf the research peptides marketed for fat loss in the grey market, essentially none are FDA-approved for weight loss — the approved weight-loss medicines are the GLP-1/GIP drugs, not these

Most 'research peptides' marketed for weight loss, muscle, or anti-aging are experimental and not FDA-approved for anything — 'approved abroad' is not the same as proven.
For each, ask whether a human randomized trial exists for the claimed use — many have only animal or mechanistic data, and 'promising in mice' is not human evidence.
Be cautious when the only positive data come from a single group or the seller; the FDA-approved exceptions are narrow (semaglutide, tirzepatide; bremelanotide as Vyleesi for sexual desire, not weight).
Grey-market vials guarantee no identity, dose, sterility, or purity, and injecting unregulated peptides carries real risk.

"Peptides" has become a catch-all marketing term covering everything from FDA-approved obesity medicines to unapproved grey-market research chemicals sold for fat loss, muscle, tanning, sleep, and anti-aging. This guide is an evidence-first index: every peptide we have reviewed, grouped by what it is actually used for, each with a one-line verdict and a link to the full review. The honest through-line is that the medicines with large, replicated human weight-loss trials are the GLP-1 and GIP drugs — semaglutide (-14.9% in STEP-1 ^[1]) and tirzepatide (-20.9% in SURMOUNT-1 ^[2]) — while most of the "peptides" sold online for weight loss have little or no human evidence for that use.

How to read any peptide claim

Is it FDA-approved, and for what? A few are (tirzepatide, semaglutide; bremelanotide as Vyleesi for sexual desire). Most "research peptides" are not approved for anything, and "approved abroad" is not the same as proven.
Is there a human randomized trial for the claimed use? Many peptides have only animal or mechanistic data. "Promising in mice" is not evidence of a human benefit.
Who funded and replicated the studies? Be cautious when the only positive data come from a single group, or from the seller.
What is the product, really? Grey-market vials have no guarantee of identity, dose, sterility, or purity, and injecting unregulated peptides carries real risk.

Weight-loss & metabolic peptides

Peptides for weight loss: the full evidence review — the definitions, the three categories, and which actually have human data
Non-GLP-1 peptides for fat loss — the broader landscape of what is and isn't supported
Tesamorelin (Egrifta) — FDA-approved, but only for HIV-associated visceral fat; not a general weight-loss drug
Cagrilintide — investigational amylin analogue (the amylin half of CagriSema)
MOTS-c — mitochondrial "exercise mimetic"; mouse metabolism data, no human weight-loss trial
5-Amino-1MQ — oral NNMT inhibitor (not a peptide); fat loss in obese mice, zero human trials
AOD-9604 — built as an anti-obesity drug; positive in mice, negative in the human phase 2
Tesofensine — strong phase-2 obesity data (TIPO-1) that stalled in phase 3; not approved

Growth-hormone secretagogues (GH/IGF-1 peptides)

Sermorelin — GHRH analogue once approved (Geref) for pediatric GH deficiency, now discontinued; no weight-loss RCT
CJC-1295 (and the CJC-1295/ipamorelin stack) — long-acting GHRH analogue; no FDA approval, no weight-loss RCT
Ipamorelin — selective GH secretagogue; its only clinical RCT was for post-op ileus
MK-677 (ibutamoren) — oral ghrelin mimetic that actually raises appetite and body weight, not fat loss

Recovery, longevity & other research peptides

BPC-157 — "Body Protection Compound"; animal-only healing data, no human RCT, no fat-loss mechanism
TB-500 — thymosin beta-4 fragment; WADA-banned recovery peptide, animal-only, no human trial
GHK-Cu (copper peptide) — real but modest topical skin evidence; injectable systemic use is unproven
Epitalon (epithalon) — telomerase/longevity claims resting on thin, single-group, unreplicated data
Thymosin alpha-1 (Zadaxin) — immune peptide approved abroad for hepatitis; not FDA-approved, not for weight loss
Semax — Russian intranasal nootropic; mostly Russian-language, unreplicated human data
Selank — Russian anxiolytic peptide; small, unreplicated clinical data
DSIP (delta sleep-inducing peptide) — named for a sleep effect, but the human evidence is old, small, and inconsistent
PT-141 (bremelanotide) — FDA-approved as Vyleesi for sexual desire disorder; not a weight-loss peptide
Melanotan 2 — unapproved tanning peptide that regulators warn against; linked to changing moles and melanoma

A note on grey-market "research peptides"

Most of the peptides above are sold online labeled "for research use only, not for human consumption." That label exists because they are not approved human medicines. Beyond the lack of efficacy evidence for many of the marketed uses, unregulated injectable peptides carry risks of contamination, wrong dose, and wrong identity. If you are considering any of these, talk to a licensed clinician — and for weight loss specifically, the FDA-approved options have far stronger evidence.

Frequently Asked Questions

References

1.Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PMID: 33567185.
2.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022. PMID: 35658024.

Best Oral Peptides for Weight Loss (2026): What the Evidence Actually Shows vs the Hype

The honest 2026 answer to 'best oral peptides for weight loss': only TWO oral GLP-1 medications are FDA-approved as of May 2026 — Rybelsus (oral semaglutide, type 2 diabetes ONLY since 2019) and Foundayo (orforglipron, chronic weight management since April 1, 2026). Foundayo is technically a non-peptide small molecule grouped with the oral GLP-1s. Everything else commonly searched — BPC-157, TB-500, AOD-9604, selank, ipamorelin, sermorelin, MOTS-c, tesamorelin for general weight loss — is either an unapproved 'research peptide' (illegal to sell for human consumption), an investigational compound with no FDA approval for weight loss, approved for a different indication (tesamorelin is HIV-associated lipodystrophy ONLY), or a trial compound with no published phase 3 weight-loss data. This article is the evidence-vs-hype framing, the verbatim FDA-status of every commonly-searched peptide, the published trial data (or its absence), and the pivot to FDA-approved alternatives.

13 min read

Do You Need a Prescription for Compounded Semaglutide? (Yes — Here's Why) (2026)

Yes — compounded semaglutide is a prescription medication. A licensed prescriber must evaluate you and a licensed pharmacy must dispense it. How the legitimate process works, and the red flags.

7 min read

What Are Peptides for Weight Loss? Definition, Compounded Peptide Landscape + Evidence Review

Peptides for weight loss fall into three distinct categories: (1) FDA-approved peptide drugs — Wegovy (semaglutide 31aa, -14.9% STEP-1 PMID 33567185), Zepbound (tirzepatide 39aa, -20.9% SURMOUNT-1 PMID 35658024), Saxenda (liraglutide 34aa, -8.0% SCALE PMID 26132939); (2) compounded peptide versions of those drugs from 503A pharmacies — not FDA-approved products, regulatory landscape changed post-Feb 2025; (3) research peptides (BPC-157, AOD-9604, MOTS-c, GHK-Cu, sermorelin) — NONE FDA-approved for weight loss, no Phase 3 human weight-loss RCT in PubMed. Tesamorelin (Egrifta SV) is FDA-approved but ONLY for HIV-associated lipodystrophy (DailyMed SetID 3d783378 verbatim: 'reduction of excess abdominal fat in HIV-infected patients with lipodystrophy') — not for general weight loss. Foundayo (orforglipron) is FDA-approved for weight management (April 2026) but is NOT a peptide — it is a non-peptide small-molecule GLP-1 RA. Verified 2026-05-10.

16 min read

Rapamycin for Weight Loss & Metabolic Health: What the Evidence Actually Shows

What the evidence really shows about rapamycin (sirolimus) for weight loss and metabolic health: no human weight-loss RCTs, a metabolic paradox where chronic dosing worsens insulin sensitivity and lipids (mTORC2), landmark animal longevity data, small human healthspan trials, safety caveats, and its strictly off-label status.

9 min read

Senolytics for Weight Loss & Metabolic Health: What the Evidence Actually Shows

What the evidence really shows about senolytics (dasatinib + quercetin, fisetin) for weight loss and metabolic health: zero human weight-loss trials, metabolic benefit demonstrated only in mice, tiny early-phase human safety pilots in kidney and lung disease, real safety caveats, and no FDA approval as senolytics.

9 min read

Metabolic Longevity: Do Anti-Aging Drugs & Supplements Actually Help Weight and Metabolism?

An evidence-first ranking of the popular 'metabolic longevity' interventions — GLP-1 agonists, metformin, berberine, NAD precursors, rapamycin, and senolytics — by how much human weight and metabolic evidence actually supports them, with a link to each fully-cited deep-dive.

6 min read

Peptides A-Z: An Evidence-First Guide to Every Peptide We've Reviewed

How to read any peptide claim

Weight-loss & metabolic peptides

Growth-hormone secretagogues (GH/IGF-1 peptides)

Recovery, longevity & other research peptides

Frequently Asked Questions

References

Where to get GLP-1: vetted providers

Bodybuilding Health+

Brightmeds

Direct Meds

How to read any peptide claim

Weight-loss & metabolic peptides

Growth-hormone secretagogues (GH/IGF-1 peptides)

Recovery, longevity & other research peptides

Frequently Asked Questions

References

Related research

Where to get GLP-1: vetted providers

Bodybuilding Health+

Brightmeds

Direct Meds